neurodegenerative Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Loss of intrinsic GABAergic neurons of the of the Vladimir Putin(caudate putamen)

A

Huntington’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Excessive cortical activity, chorea, hyperkinesia

A

Huntington’s disease
chorea-a neurological disorder characterized by jerky involuntary movements affecting especially the shoulders, hips, and face.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are lewy bodies?

A

abnormal intracellular proteins clump or aggregate
a synuclein ubiquitin
Parkinson’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Progressive degeneration of y-aminobutyric acid (GABA) neurons in the basal ganglia and cortex

A

Huntington disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

And anti viral agent used to treat mild to moderate Parkinson disease, Anti cholinergic properties

A

Amantadine/Symmetrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

loss of intrinsic cortical neurons beginning in the entorhinal cortex that spreads to the whole cortex resulting in a loss of memory and logical thinking

A

Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Potent dopamine D1 and D2 receptor agonist

A

Apomorphine(apokyn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

name two anticholinesterase used to treat Alzheimer’s

A

donepezil(Aricept)

galantamine (razadyne)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

With this disease there is a marked decrease in cholinergic neuron activity as a result these patients are very sensitive to central nervous system effects of muscarinic antagonist

A

Alzheimer’s patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Parkinson’s disease is an issue with the neurotransmitter______ and decreased activation of the _______pathway which results and an increased activation of the_______ pathway. Parkinson’s is a ____kinetic disorder.

A

Parkinson’s disease there’s an issue with the neurotransmitter dopamine and decreased activation of the direct pathway which results in an increased activation of the indirect pathway. Parkinson’s is a hypokinetic disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

these drugs are used to treat huntington’s by decreasing dopamine neurotransmission, depletion of dopamine and nerve terminals by inhibition of VMAT

A

tetra-benazine/ xenazine

deu-tetra-benazine/ austedo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

side effect of being metabolised to methamphetamine or L amphetamine which may account for the side effect of anxiety and insomnia

A

Selegine/eldepryl-selective irreversible MAOB inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GABA and decreased indirect pathway, which disease?

A

Huntington’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Parkinson’s disease also results in some neurodegenerative signs related to autonomic degeneration
4

A

orthostatic hypotension
Significant autonomic dysfunction-hemodynamic instability
Bowel and bladder and mobility
Incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Major side effects similar to carbidopa-levodopa/Sinemet-orthostatic hypotension, nausea vomiting Constipation, psychotic reactions, cardiac dysrhythmias, dyskinesias

A

Apomorphine(apokyn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the longer duration patch form of Ropinirole/requip

A

Rigatoni

Rotigone/neupro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Parkinson’s disease can also include some non motor cognitive and emotional symptoms such as?

A
fatigue 
loss of interest in religion 
Alexithymia-Loss of one's ability to recognize one's own emotions as well as the emotions of others
dementia 
Depression of mood
Anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

a key relay station in the initiation and control of coordinated patterns of movement

A

the basal ganglia/basal nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

these drugs treat Huntington’s disease by blockade of postsynaptic dopamine

A

Antipsychotic drugs haloperidol and chlorpromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

b-amyloid, tau protein which disorder

A

Alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Loss of dopamine neurons of the substantia nigra that innervate the basal nuclei (basal ganglia)

A

Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

side effects include may exacerbate carbidopa-levodopa/Sinemet induced dyskinesias, confusing and hallucinations

A

Selegine/eldepryl-selective irreversible MAOB inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

why are typical antipsychotics not administered to Parkinson disease patients

A

blocking D2

typical antipsychotics are D2 antagonist

24
Q

What causes the Parkinson psychosis hallucinations and delusions

A

D2

25
Q

A muscarinic receptor antagonist used to reduce cholinergic dominance in Parkinson’s

A

Benztropine(Cogentin)

26
Q

Parkinson’s adjunct therapy that peripherally inhibits COMT-Blocks conversion of L-DOPA to 3-O-methyldopa increasing L-DOPA availability

A

Entacapone/comtan

27
Q

Acts on dopamine one and two, a rescue medication, short acting, approved for subq doses?
this drug must be taken with what?
How must the IV infusion be administered?

A

Apomorphine(apokyn) D1&2 agonist
Antiemetic
long term in-dwelling venous catheter

28
Q

name a positive allosteric modulator of nicotinic acetylcholine receptors used to treat Alzheimer’s

A

galantamine (razadyne)

anticholinesterase

29
Q

What’s some anesthetic implications for Parkinson’s disease

A

Short half life of L-DOPA, frequent doses-may have to administer and long surgeries
avoid dopamine antagonists
avoid dopamine receptor blockade for PONV prophylaxis

30
Q

What causes the adverse side effects of dopamine?

A

Dopamine is metabolised in norepinephrine and epinephrine in the CNS and in the periphery. side effects are what you would expect from high catecholamine levels

31
Q

Inhibits the metabolism of L-DOPA in the periphery by action on AADC(aromatic amino acid decarboxylase)

A

Carbidopa/sinemet

32
Q

dopamine and decreased direct pathway, which disease?

A

Parkinson’s

33
Q

Noncompetitive glutamate NMDA receptor antagonists used to treat Alzheimer’s

A

Memantine/namzaric

34
Q

The treatment strategy of which disease is to decrease dopamine neurotransmission?
what mechanism of the disease causes this to be a solution?

A

Huntington disease
because there is a destruction of the GABA neurons in the basal ganglia and cortex/indirect pathway, the dopamine mediated direct pathway is overactive.

35
Q

an inverse agonist at serotonin 5 HT-2A receptors-

A

pimavanserin(nuplazid)
pimps might work out of vans too

the one that’s similar to LSD
far out man
hippies live in vans like Brennan

36
Q

Dead and dying nerve cells contain neurofibrillary tangles which are made up of twisted strands of tau protein

A

Alzheimer’s

Tau protein stabilize microtubules, Microtubules provide platforms for intracellular transport

Toxic b amyloid oligomers Impair basic neuronal processes and activate immune system causing inflammation

37
Q

What might interact with carbidopa-levodopa/sinemet reducing its efficacy?

A

Pyridoxine(vitamin B6)
accelerate systemic metabolism of levodopa by enhancing the effectiveness of decarboxylase thereby decreasing availability of the amino acid to the brain

38
Q

Name of dopamine receptor agonist primarily at D2, adjunct Parkinson therapy

A

Ropinirole/requip

39
Q

To prevent a life threatening hypertensive crisis and hyperpyrexia, non selective Mao inhibitors should be discontinued how many days before carbidopa-levodopa/Sinemet is administered

A

14 days

40
Q

Parkinson’s is a profound loss of dopaminergic neurons where?

A

substantia nigra

41
Q

a synuclein ubiquitin which disorder

A

Parkinson’s disease

42
Q

Used for management of drug induced parkinsonism and schizophrenic patients treated with antipsychotics(potent D2 receptor antagonist), Preferred treatment of neuroleptic induced extrapyramidal syndrome

A

Benztropine(Cogentin)

Used for management of drug induced parkinsonism and schizophrenic patients treated with antipsychotics(potent D2 receptor antagonist), Preferred treatment of neuroleptic induced extrapyramidal syndrome

43
Q

the basal ganglia consist of three structures

A

Caudate nucleus
Putamen
Globus pallidus

44
Q

Describe some of the characteristic motor symptoms of Parkinson’s disease

A

resting tremor(most obvious early symptom)
rigidity and stiffness
stooped posture
shuffling gait
poor righting reflex-balance
Bradykinesia-slowness of movement, difficulty walking
Difficulty speaking and swallowing
Difficulty writing (tiny, crowded handwriting)
mask like face
in advanced stages of Parkinson’s disease patients become virtually immobile

45
Q

What are two common characteristics of neurodegenerative disorders?

A

accumulation abnormal protein

progressive and irreversible loss of neurons in the brain

46
Q

Within the basal nuclei Which pathway facilitates movement and which pathway inhibits movement?

A

Direct pathway facilitates movement

Indirect pathway inhibits movement

47
Q

what part of the brain does Alzheimer’s begin in?

A

entorhinal cortex

48
Q

Adverse side effects include cardiac arrhythmias and transit tachycardia, nausea and vomiting, and orthostatic hypotension. what is the nausea and vomiting caused by?

A

L-Dopa

dopamine D receptors on the chemo trigger zone

49
Q

carbidopa-levodopa/sinemet is contraindicated in combination with which drugs? two different classes

A

dopamine receptor antagonist-typical antipsychotic drug
chlorpromazine, Thorazine
haloperidol, Haldol
flupenthixol, fluanxol

Non selective irreversible Mao inhibitors
Phenelizine/nardil
Ipronizad(marsilid, iprazid, ipronid

50
Q

Huntington protein which disorder

A

Huntington’s disease

51
Q

This disease has a loss of dopaminergic input/inhibition, which leads to acetylcholine mediated excitation of inhibitory GABA neurons.
GABA has done let loose like it’s spring break in Myrtle Beach 1995.

A

Parkinson disease

52
Q

dopamine precursor that crosses the blood brain barrier by active transport to stimulate dopamine synthesis

A

levodopa(l-dopa)

53
Q

What treatment strategy/drug would block dopamine degradation in the brain?

A

Selegine/eldepryl-selective irreversible MAOB inhibitor

54
Q

Administration of this drug has the benefits of a lower dose of L-DOPA being administered, more L-DOPA reaches the brain, reduction in peripheral side effects, resulting in less peripheral conversion of L-DOPA to dopamine and norepinephrine

A

carbidopa-levodopa/sinemet

55
Q

The disease process progresses to include lateral temporal and parietal lobes and when severe associated with loss of neurons throughout the cortex including frontal and occipital lobe, severe cortical atropy in later stages

A

Alzheimer’s

56
Q

Usually develops in the mid 30s to 40s, early symptoms include mental decline, problems with mood and cognition, general lack of coordination and an unsteady gait. as the disease advances coordinated movements become difficult, uncoordinated involuntary jerking or twitching movements known as chorea, further mental decline into dementia

A

Huntington’s disease

57
Q

Reduced cortical stimulation hypokinetic disorder

A

Parkinson’s